Skip to main content
Ajay Nooka, MD, Oncology, Atlanta, GA, Emory University Hospital Midtown

AjayKNookaMD

Oncology Atlanta, GA

Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine

Dr. Nooka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nooka's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Canton Medical Education Foundation
    Canton Medical Education FoundationResidency, Internal Medicine, 2005 - 2008
  • Andhra Medical College NTR
    Andhra Medical College NTRClass of 2000

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2009 - 2023
  • OH State Medical License
    OH State Medical License 2005 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African Americans
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in First Relapse Patients (pts) with Multiple Myeloma...
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrang... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Patients with Low-Risk Myeloma Could Prove Ideal for Daratumumab Therapy
    Patients with Low-Risk Myeloma Could Prove Ideal for Daratumumab TherapySeptember 26th, 2019
  • Winship Receives NCI Grant in Multiple Myeloma
    Winship Receives NCI Grant in Multiple MyelomaSeptember 10th, 2018
  • OncLive® Presents State of the Science Summit™ on Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31st, 2019
  • Join now to see all

Hospital Affiliations